Clinical trial NCT01797692: Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
Official title: Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Prostate Cancer Cured
Healthy Population Control
Keywords: prostate cancer cured
aged patients
Lead sponsor: Centre Francois Baclesse
Sponsor class: OTHER
First posted: 2013-02-22
Enrollment: 74
Sex: MALE
Minimum age (years): 75
Standard ages: OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: This is a multicenter pilot study, proposed for cases and controls 3 departments in France.

Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are healthy subjects selected by lottery on voter list.

Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

Detailed description: Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

During this consultation, ADL, IADL and MMS questionnary will be completed. neurocognitif testing will be done.

Eligibility criteria: Inclusion Criteria for patients:

* Patients aged 75 years or more
* Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years
* Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer
* Patients considered cured of prostate cancer (regardless of initial treatment)
* Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric
* Signature of consent
* Affiliation to a social security system

Exclusion Criteria for patients:

* Patients under 75 years
* Patients with recurrent or metastatic
* Persons deprived of liberty or under guardianship

Inclusion Criteria for control population:

* Male subjects
* Subjects of 75 years or more
* Subjects that do not have cancer or a history of cancer (except basal cell skin cancer)
* Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics
* Subjects who gave their written consent to participate in the study

Primary outcomes:
measure: impact of treatments
timeFrame: 10 years after treatment for cancer prostate
Secondary outcomes:
measure: Evaluate the anxiety of patients and controls
timeFrame: 10 years after treatment for cancer prostate
measure: Assessing depression patients and controls
timeFrame: 10 years after treatments for cancer prostate
measure: Assess the nutritional status of patients and controls
timeFrame: 10 years after treatments for cancer prostate
Other outcomes:
Locations:
city: Strasbourg
country: France
facility: Hopitaux universitaires de Strasbourg
state: Bas-Rhin
city: Caen
country: France
facility: Centre François BACLESSE
state: Calvados
city: Albi
country: France
facility: Clinique Claude BERNARD
city: Besancon
country: France
facility: CHRU
city: Castres
country: France
facility: CHIC
Study officials:
References: